Jerome P. Richie

Gene expression correlates of clinical prostate cancer behavior

Dinesh Singh, Phillip G. Febbo, Kenneth N. Ross et al. · Cancer Cell · 2002 · 2.5K citations · Full text

Life Sciences, Molecular Biology, Oncology +14

Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy <i>in vivo</i>

Omid C. Farokhzad, Jianjun Cheng, Benjamin A. Teply et al. · Proceedings of the National Academy of Sciences · 2006 · 1.6K citations · Full text

Pharmacy, Oncology, Pharmaceutics +17

Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic Disease

William J. Catalona, Alan W. Partin, Kevin M. Slawin et al. · JAMA · 1998 · 1.2K citations

Medicine, Oncology, Urology +17

Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era

Anthony V. D’Amico, Richard Whittington, S. Bruce Malkowicz et al. · Cancer · 2002 · 353 citations · Full text

Medicine, Surgery, Urology +17

Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging

William J. Catàlona, Paula C. Southwick, Kevin M. Slawin et al. · Urology · 2000 · 336 citations

Medicine, Oncology, Urology +17